Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells

Cancer Research

Volumn 66, Issue 24, 2006, Pages 11726-11735

  Santra, Manoranjan ^a   Zhang, Xuepeng ^a   Santra, Sutapa ^a   Jiang, Feng ^a   Chopp, Michael ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; COMPLEMENTARY DNA; DOUBLECORTIN; PHOSPHATASE; PROTEIN P14ARF; SMALL INTERFERING RNA; SPINOPHILIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CANCER CELL; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG SYNTHESIS; ENZYME ACTIVE SITE; GENE EXPRESSION; GENE INTERACTION; GENE TRANSFER; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ANIMALS; BRAIN NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; GLIOBLASTOMA; HUMANS; LENTIVIRUS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MITOSIS; NEUROPEPTIDES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; RATS; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL; TRANSCRIPTION, GENETIC;

EID: 33846236371     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1978     Document Type: Article

References (47)

1. Legler JM, Gloeckler Ries LA, Smith MA, et al. Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999;91:1382-90.
2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
3. Rich JN, Hans C, Jones B, et al. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 2005;6510:4051-8.
4. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, Martin GR. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981;26:99-105.
5. Schultz C, Lemke N, Ge S, Golembieski WA, Rempel SA. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res 2002;6221:6270-7.
6. Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000;60:6116-33.
7. des Portes V, Pinard JM, Billuart P, et al. A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar hetrotropia and lissencephaly syndrome. Cell 1998;92:51-61.
8. Gleeson JG, Allen KM, Fox JW, et al. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 1998;92:63-72.
9. Gleeson JG, Lin PT, Flanagan LA, Walsh CA. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 1999;23:257-71.
10. Horesh D, Sapir T, Francis F, et al. Doublecortin, a stabilizer of microtubules. Hum Mol Genet 1999;8:1599-610.
11. Francis F, Koulakoff A, Boucher D, et al. Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 1999;23:247-56.
12. Gleeson JG, Walsh CA. Neuronal migration disorders: from genetic diseases to developmental mechanisms. Trends Neurosci 2000;238:352-9.
13. Li L, He F, Litofsky NS, Recht LD, Ross AH. Profiling of genes expressed by PTEN haploinsufficient neural precursor cells. Mol Cell Neurosci 2003;24:1051-61.
14. Glass R, Synowitz M, Kronenberg G, et al. Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J Neurosci 2005;2510:2637-46.
15. Zhang Z, Jiang Q, Jiang F, et al. In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage 2004;231:281-7.
16. Santra M, Lui XS, Zhang J, Zhang RL, Zhang ZG, Chopp M. Ectopic expression of doublecortin protects adult mouse progenitor cells and human glioma cells from severe oxygen and glucose deprivation. Neuroscience 2006;92:7016-20.
17. Santra M, Skorski T, Calabretta B, Lattime EC, Iozzo RV. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci U S A 1995;9215:7016-20.
18. Santra M, Katakowski M, Zhang RL, et al. Protection of adult mouse progenitor cells and human glioma cells by de novo decorin expression in an oxygen- and glucose-deprived cell culture model system. J Cereb Blood Flow Metab 2006;26:1311-22.
19. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003;7716:8957-61.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 2001;254:402-8.
21. Agami R, Bernards R. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 2000;1021:55-66.
22. Santra M, Eichstetter I, Iozzo RV. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem 2000;27545:35153-61.
23. Ross ME, Allen KM, Srivastava AK, et al. Linkage and physical mapping of X-linked lissencephaly/SBH (XLIS): a gene causing neuronal migration defects in human brain. Hum Mol Genet 1997;64:555-62.
24. Gdalyahu A, Ghosh I, Levy T, et al. DCX a new mediator of the JNK pathway. EMBO J 2004;234:823-32.
25. 2-terminal kinase are expressed in primary glial tumors. Cancer Res 2003;631:250-5.
26. Schwartz MA. Integrins, oncogenes, and anchorage independence. J Cell Biol 1997;139:575-8.
27. Tamrakar S, Rubin E, Ludlow JW. Role of pRB dephosphorylation in cell cycle regulation. Front Biosci 2000;5:D121-37.
28. Vivo M, Calogero RA, Sansone F, et al. The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein. J Biol Chem 2001;27617:14161-9.
29. Han SY, Kim SH, Heasley LE. Differential gene regulation by specific gain-of-function JNK1 proteins expressed in Swiss 3T3 fibroblasts. J Biol Chem 2002;27749:47167-74.
30. Liu F, Wagner S, Campbell RB, Nickerson JA, Schiffer CA, Ross AH. PTEN enters the nucleus by diffusion. J Cell Biochem 2005;962:221-34.
31. Shmueli A, Gdalyahu A, Sapoznik S, Sapir T, Tsukada M, Reiner O. Site-specific dephosphorylation of doublecortin (DCX) by protein phosphatase 1 (PP1). Mol Cell Neurosci 2006. Epub ahead of print.
32. Rempel SA, Golembieski WA, Fisher JL, Maile M, Nakeff A. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. J Neurooncol 2001;532:149-60.
33. Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B, Iozzo RV. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest 1997;1001:149-57.
34. Santra M, Reed CC, Iozzo RV. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J Biol Chem 2002;27738:35671-81.
35. Biglari A, Bataille D, Naumann U, et al. Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model. Cancer Gene Ther 2004;1111:721-32.
36. Li J, Yen C, Liaw D, et al. PTEN, a putative tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-7.
37. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;4:356-62.
38. von Deimling A, von Ammon K, Schoenfeld D, Wiestler O, Seizinger B, Louis D. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3:19-26.
39. Lang FF, Miller DC, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994;81:427-36.
40. Furnari FB, Lin H, Huang HS, Cavenee WK. Growth suppression of glioma cells by Pten requires a functional phosphatase catalytic domain. Proc Natl Acad Sci U S A 1997;94:12479-84.
41. Cheney IW Johnson DE, Vaillancourt MT, et al. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 1998;5811:2331-4.
42. Cohen P. The origins of protein phosphorylation. Nat Cell Biol 2002;45:E127-30.
43. Inui S, Sanjo H, Maeda K, Yamamoto H, Miyamoto E, Sakaguchi N. Ig receptor binding protein 1 (α4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. Blood 1998;922:539-46.
44. MacMillan LB, Bass MA, Cheng N, et al. Brain actin-associated protein phosphatase 1 holoenzymes containing spinophilin, neurabin, and selected catalytic subunit isoforms. J Biol Chem 1999;27450:35845-54.
45. Rubin E, Tamrakar S, Ludlow JW. Protein phosphatase type 1, the product of the retinoblastoma susceptibility gene, and cell cycle control. Front Biosci 1998;3:D1209-19.
46. Yamashita K, Yasuda H, Pines J, et al. Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells. EMBO J 1990;913:4331-8.
47. Gavin AC, Tsukitani Y, Schorderet-Slatkine S. Induction of M-phase entry of prophase-blocked mouse oocytes through microinjection of okadaic acid, a specific phosphatase inhibitor. Exp Cell Res 1991;1921:75-81.